Guided Therapeutics (GTHP) Enterprise Value (2010 - 2025)
Guided Therapeutics' (GTHP) quarterly Enterprise Value came in at -$63000.0 in Q4 2025, up 83.76% year-on-year from -$34283.3 in Q4 2024, and up 27.59% quarter-over-quarter from -$87000.0 in Q3 2025.
Guided Therapeutics (GTHP) Enterprise Value (2010 - 2025) Analysis & Trends
Guided Therapeutics has disclosed Enterprise Value across 16 years of filings, most recently posting -$63000.0 for Q4 2025.
- Enterprise Value for Q4 2025 came in at -$63000.0, up 83.76% year-over-year; the trailing twelve-month figure through Dec 2025 was -$63000.0 (up 83.76% YoY), and the FY2025 annual result was -$63000.0, up 83.76% from the prior year.
- Enterprise Value came in at -$63000.0 for Q4 2025 at Guided Therapeutics, up from -$87000.0 in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$63000.0 in Q4 2025 to a low of -$2.7 million in Q3 2022.
- The 5-year median for Enterprise Value is -$566000.0 (2021), against an average of -$790150.0.
- Across the five-year window, Enterprise Value slumped 5838.1% in 2021 and surged 83.76% in 2025, its largest moves.
- Guided Therapeutics' Enterprise Value stood at -$643000.0 in 2021, then plunged by 259.72% to -$2.3 million in 2022, then jumped by 74.45% to -$591000.0 in 2023, then jumped by 34.35% to -$388000.0 in 2024, then soared by 83.76% to -$63000.0 in 2025.
- The last three Enterprise Value figures came in at -$63000.0 (Q4 2025), -$87000.0 (Q3 2025), and -$185000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -6.66 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -2.88 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -8.17 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -1.21 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -3.67 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -3.09 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -1.12 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -2.07 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -426.00 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | -63,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -63,000.00 |
| Sep 30, 2025 | -87,000.00 |
| Jun 30, 2025 | -185,000.00 |
| Mar 31, 2025 | -115,000.00 |
| Dec 31, 2024 | -388,000.00 |
| Sep 30, 2024 | -194,000.00 |
| Jun 30, 2024 | -275,000.00 |
| Mar 31, 2024 | -445,000.00 |
| Dec 31, 2023 | -591,000.00 |
| Sep 30, 2023 | -731,000.00 |
| Jun 30, 2023 | -1.36 Mn |
| Mar 31, 2023 | -1.84 Mn |
| Dec 31, 2022 | -2.31 Mn |
| Sep 30, 2022 | -2.70 Mn |
| Jun 30, 2022 | -446,000.00 |
| Mar 31, 2022 | -725,000.00 |
| Dec 31, 2021 | -643,000.00 |
| Sep 30, 2021 | -541,000.00 |
| Jun 30, 2021 | -922,000.00 |
| Mar 31, 2021 | -1.25 Mn |